Verastem, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Verastem, Inc. (VSTM) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $4.10 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-05-10
- Verastem, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was $4.10M, a 271.01% increase year-over-year.
- Verastem, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was $1.03M, a 93.24% decline year-over-year.
- Verastem, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was $3.73M.
- Verastem, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was $31.11M, a 247.89% increase year-over-year.
- Verastem, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $36.97M.
- Verastem, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$27.06M, a 162.72% decline from fiscal 2014.
- Verastem, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was $43.14M.
- Verastem, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$23.39M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 5 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 20 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 23 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 26 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 29 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 32 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 35 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 38 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 41 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 44 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-03-31 | $4.10M 10-Q · filed 2017-05-10 | $5.12M derived: sum of 2 quarters · filed 2017-05-10 | $8.85M derived: sum of 3 quarters · filed 2017-05-10 | $39.96M derived: sum of 4 quarters · filed 2017-05-10 | ||||||||||
| 2016-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-23 | $4.76M derived: sum of 2 quarters · filed 2017-03-23 | $35.86M derived: sum of 3 quarters · filed 2017-03-23 | $36.97M 10-K · filed 2017-03-23 | ||||||||||
| 2016-09-30 | $3.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $34.84M derived: sum of 2 quarters · filed 2016-11-07 | $35.94M 10-Q · filed 2016-11-07 | $51.13M derived: sum of 4 quarters · filed 2017-05-10 | ||||||||||
| 2016-06-30 | $31.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $32.21M 10-Q · filed 2016-08-08 | $47.40M derived: sum of 3 quarters · filed 2017-05-10 | $43.61M derived: sum of 4 quarters · filed 2017-05-10 | ||||||||||
| 2016-03-31 | $1.10M 10-Q · filed 2017-05-10 | $16.30M derived: sum of 2 quarters · filed 2017-05-10 | $12.50M derived: sum of 3 quarters · filed 2017-05-10 | $21.45M derived: sum of 4 quarters · filed 2017-05-10 | ||||||||||
| 2015-12-31 | $15.19M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-23 | $11.40M derived: sum of 2 quarters · filed 2017-03-23 | $20.34M derived: sum of 3 quarters · filed 2017-03-23 | -$27.06M 10-K · filed 2017-03-23 | ||||||||||
| 2015-09-30 | -$3.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $5.15M derived: sum of 2 quarters · filed 2016-11-07 | -$42.25M 10-Q · filed 2016-11-07 | -$28.77M derived: sum of 4 quarters · filed 2017-03-23 | ||||||||||
| 2015-06-30 | $8.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$38.46M 10-Q · filed 2016-08-08 | -$24.98M derived: sum of 3 quarters · filed 2017-03-23 | -$17.36M derived: sum of 4 quarters · filed 2017-03-23 | ||||||||||
| 2015-03-31 | -$47.40M 10-Q · filed 2016-05-09 | -$33.92M derived: sum of 2 quarters · filed 2017-03-23 | -$26.30M derived: sum of 3 quarters · filed 2017-03-23 | -$8.38M derived: sum of 4 quarters · filed 2017-03-23 | ||||||||||
| 2014-12-31 | $13.48M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-23 | $21.10M derived: sum of 2 quarters · filed 2017-03-23 | $39.02M derived: sum of 3 quarters · filed 2017-03-23 | $43.14M 10-K · filed 2017-03-23 | ||||||||||
| 2014-09-30 | $7.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $25.54M derived: sum of 2 quarters · filed 2015-11-09 | $29.66M 10-Q · filed 2015-11-09 | $32.45M derived: sum of 4 quarters · filed 2016-03-03 | ||||||||||
| 2014-06-30 | $17.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $22.04M 10-Q · filed 2015-08-10 | $24.83M derived: sum of 3 quarters · filed 2016-03-03 | -$18.59M derived: sum of 4 quarters · filed 2016-03-03 | ||||||||||
| 2014-03-31 | $4.12M 10-Q · filed 2015-05-11 | $6.91M derived: sum of 2 quarters · filed 2016-03-03 | -$36.51M derived: sum of 3 quarters · filed 2016-03-03 | -$44.53M derived: sum of 4 quarters · filed 2016-03-03 | -$101.86M 10-Q · filed 2014-05-08 | |||||||||
| 2013-12-31 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | -$40.63M derived: sum of 2 quarters · filed 2016-03-03 | -$48.64M derived: sum of 3 quarters · filed 2016-03-03 | -$23.39M 10-K · filed 2016-03-03 | -$105.98M 10-K · filed 2014-03-06 | |||||||||
| 2013-09-30 | -$43.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$51.44M derived: sum of 2 quarters · filed 2014-10-30 | -$26.18M 10-Q · filed 2014-10-30 | -$21.29M derived: sum of 4 quarters · filed 2015-03-10 | -$108.77M 10-Q · filed 2013-11-12 | |||||||||
| 2013-06-30 | -$8.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $17.24M 10-Q · filed 2014-08-07 | $22.13M derived: sum of 3 quarters · filed 2015-03-10 | $24.24M derived: sum of 4 quarters · filed 2015-03-10 | -$65.35M 10-Q · filed 2013-08-13 | |||||||||
| 2013-03-31 | $25.25M 10-Q · filed 2014-05-08 | $30.14M derived: sum of 2 quarters · filed 2015-03-10 | $32.25M derived: sum of 3 quarters · filed 2015-03-10 | $27.58M derived: sum of 4 quarters · filed 2015-03-10 | -$57.34M 10-Q · filed 2013-05-09 | |||||||||
| 2012-12-31 | $4.89M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-10 | $7.00M derived: sum of 2 quarters · filed 2015-03-10 | $2.33M derived: sum of 3 quarters · filed 2015-03-10 | -$45.86M 10-K · filed 2015-03-10 | -$82.59M 10-K · filed 2013-03-26 | |||||||||
| 2012-09-30 | $2.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$2.56M derived: sum of 2 quarters · filed 2013-11-12 | -$50.75M 10-Q · filed 2013-11-12 | -$86.63M derived: sum of 4 quarters · filed 2014-03-06 | -$87.48M 10-Q · filed 2012-11-13 | |||||||||
| 2012-06-30 | -$4.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | -$52.86M 10-Q · filed 2013-08-13 | -$88.74M derived: sum of 3 quarters · filed 2014-03-06 | -$89.11M derived: sum of 4 quarters · filed 2014-03-06 | -$89.59M 10-Q · filed 2012-08-13 | |||||||||
| 2012-03-31 | -$48.19M 10-Q · filed 2013-05-09 | -$84.07M derived: sum of 2 quarters · filed 2014-03-06 | -$84.44M derived: sum of 3 quarters · filed 2014-03-06 | -$84.91M derived: sum of 4 quarters · filed 2014-03-06 | -$84.92M 10-Q · filed 2012-05-14 | |||||||||
| 2011-12-31 | -$35.88M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-06 | -$36.25M derived: sum of 2 quarters · filed 2014-03-06 | -$36.72M derived: sum of 3 quarters · filed 2014-03-06 | -$36.72M 10-K · filed 2014-03-06 | ||||||||||
| 2011-09-30 | -$369.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | -$840.00K derived: sum of 2 quarters · filed 2012-11-13 | -$840.00K 10-Q · filed 2012-11-13 | |||||||||||
| 2011-06-30 | -$471.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | -$471.00K 10-Q · filed 2012-08-13 | ||||||||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-14 | |||||||||||||
| 2010-12-31 | -$8.00K 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |